As an obesity medicine physician, Ive seen firsthand how life-changing GLP-1 drug therapy can be for my patients
Christian Wber: has received honoraria consultancy/speaking from Apomedica, Curelator, Eli Lilly, Grnenthal, Hermes, Lundbeck, Novartis, Pfizer, Ratiopharm/Teva, and Stada
Marc Jean, DO, FACOGs care at Abundant Life Healthcare, patients receive personalized guidance to safely incorporate Ozempic into their weight management plan
Estimates suggest that if Medicare were to cover Ozempic for weight loss, it could cost the program $14 billion to $27 billion per year, or about 3% of Medicares 2022 spending
The GLP-1 utilization tracker reports prescriptions per 100,000 patients for each GLP-1, and the BMI tracker reports the distribution of U.S
Tirzepatide cardiovascular event risk assessment: a pre-specified meta-analysis